Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

3 COVID-19 vaccine candidates under active consideration of DCGI: Health Ministry

PTI
Updated: December 8th, 2020, 20:03 IST
in Coronavirus, Home News, National, Sci-Tech
0
COVID-19 vaccine

Photo courtesy: the-scientist.com

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New Delhi: Three COVID-19 vaccines candidates are under active consideration of India’s drug regulator (DCGI), the Union Health Ministry said Tuesday. The vaccines have been developed by Bharat Biotech, Serum Institute of India (SII) and Pfizer. There is hope that early licensure is possible for all or any of them, the Health Ministry informed.

Over the last four days, Pfizer, SII and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India (DCGI). All three have sought emergency use authorisation for their potential COVID-19 vaccines.

Also Read

ECI invites Rahul Gandhi to clear his doubts on Maharashtra Assembly polls

No change in instructions for SIR in Bihar, says EC after advertisement leads to confusion

12 hours ago

Indians can now get UAE’s Golden Visa without trade license, property purchase

14 hours ago

At a press briefing, NITI Aayog member (Health) VK Paul said the COVID-19 situation in India has stabilized. He said the active cases are showing a ‘clear-cut declining trend’. However, the pandemic situation in many other countries is becoming quite serious. The concern and anxiety that arose following an increase in daily cases of infection in Delhi has also settled now, he said.

Union Health Secretary Rajesh Bhushan was asked what steps would be followed by the DCGI in the absence of a water-tight emergency use authorisation law for granting licence to vaccine makers. He said not all countries’ regulatory framework or rules and acts mention emergency use authorisation.

“So, the fact that this phrase is not used in the national regulatory framework of any country does not mean that it does not have an enabling provision to accord an approval which is early and which is distinct from a regular market approval,” Bhushan said.

“India’s regulatory framework has a specific provision for grant of emergency use authorisation. Although this phrase is not used,” asserted Bhushan.

“The ‘New Drugs and Clinical Trials Rules, 2019’, clearly specifies that under specific special situations, relaxation, abbreviation, omission, or deferment of data including local clinical trial data may be considered for approval. This is our law. Similarly other countries also have their legislations,” Bhushan said.

Giving a bird’s-eye view of the Indian landscape of COVID-19 vaccines, Bhushan said that eight are at different stages of development.

One is ‘Covishield’, which is being manufactured by SII in collaboration with AstraZeneca. Another is ‘Covaxin’, which is being indigenously developed by Bharat Biotech in collaboration with ICMR. The third one is ZyCOV-D, being developed by Cadila Healthcare Ltd in Ahmedabad. It is being done in collaboration with central government’s ‘Department of Biotechnology’. Currently this vaccine is in phase two of the trials.

The fourth vaccine candidate is Sputnik V. It is being manufactured by Dr Reddy’s Lab, Hyderabad, in collaboration with Russia’s Gamaleya National Centre. The phase two trial in India is over and phase three will begin next week.

The fifth one is NVX-CoV2373, which is being developed by SII in collaboration with Novavax. Its phase three clinical trial is under consideration with the drug regulator.

The sixth vaccine candidate is Recombinant Protein Antigen based vaccine, to be manufactured by Biological E Ltd, Hyderabad, in collaboration with MIT, USA. Its pre-clinical animal studies have concluded and phase one and two human clinical trials have started. Another one is HGCO 19 being manufactured by Genova in Pune in collaboration with HDT, USA. Its pre-clinical animal studies are over and phase one and two clinical trials is set to start.

The eighth vaccine is being developed by Bharat Biotech International Ltd in collaboration with Thomas Jefferson University, USA and it is at the pre-clinical stages.

“Another vaccine, which is in initial stages, is the one being developed by Aurbindo Pharma. So there are a total of nine vaccines out of which six are in clinical trials and three are in pre-clinical stage,” Bhushan said.

 

Tags: AstraZenecaBharat BiotechCovaxinCOVID-19CovishieldDCGIPfizerSIIvaccine
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Smitarani Sahoo

December 12, 2019
#MyPaperBagChallenge

Spinoj Pattnaik

December 12, 2019
#MyPaperBagChallenge

Anasuya Sahoo

December 12, 2019
#MyPaperBagChallenge

Chinmay Kumar Routray

December 12, 2019
#MyPaperBagChallenge

Sipra Mishra

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Mandakini Dakua

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Bijswajit Pradhan

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Tapaswini Mallick

December 12, 2019
#MyPaperBagChallenge

Rajashree Pravati Mohanty

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Adyasha Priyadarsani Sendha

December 12, 2019
#MyPaperBagChallenge

Saishree Satyarupa

December 12, 2019
#MyPaperBagChallenge

Pratik Kumar

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Nishikant Rout

December 12, 2019
#MyPaperBagChallenge

Adweeti Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Pitabas Tripathy

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Archana Parida

December 12, 2019
#MyPaperBagChallenge

Faiza Firdous

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Swarit Praharaj

December 12, 2019

Archives

Editorial

Acknowledge Failure

Deputy Chief of Army Staff Lieutenant General Rahul R Singh
July 7, 2025

Deputy Chief of Army Staff Lieutenant General Rahul R Singh’s candid revelations about Operation Sindoor at a FICCI event ‘New...

Read more

Politics of Philosophy

AAKAR PATEL
July 6, 2025

The BJP’s constitution (Article 3) says, “Integral Humanism shall be the philosophy of the party.” The party’s membership form has...

Read more

India’s Spy Shift

July 5, 2025

India’s espionage architecture is quietly shifting. The appointment of Parag Jain as the new chief of RAW comes at a...

Read more

Hungary Lessons

Hungary
July 2, 2025

Revolting against oppression and seeking freedom is ingrained in human nature, something that a repressive regime finds out sooner or...

Read more
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST